Home›Companies›Healthcare›Nerveli

Nerveli Inc.

A mobile app helps people track and manage chronic pain.

Updated Nov 10, 2026·Latest SEC filing Jul 14, 2026·Suggest an edit

About Nerveli

Nerveli is a private company based in McKinney, Texas, incorporated in 2022 in Delaware. It has reported $600,000 raised in two offerings on Form D since September 2025. Its chief executive is Leon Jacobson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 29, 2026Jul 14, 2026$170,000of $500K target7$24,286DebtRule 506(b)Form D ↗
Sep 8, 2025Sep 16, 2025$430,000fully sold1$430KEquity, Simple Agreement for Future EquityRule 506(b)Form D ↗
Total, two offerings$600,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nerveli's Form D filed Jul 14, 2026.

AP
Amol Patwardhan
Chief Medical Officer and director
LJ
Leon Jacobson
CEO & Co-Founder, director
Desiree Azizoddin
Desiree Azizoddin
Co-Founder & Lead Scientific Advisor, director
TP
Ted Price
Senior Advisor and director
DM
Doug Moore
Board of Directors

Sources

  1. SECNerveli Inc. filing history
  2. CompanyNerveli privacy policy
  3. CompanyNerveli Our Story